COMPASS Pathways Plc American Depository Shares (CMPS) Stock Price
CMPSStock
$14.88+208.03%52W
Market Cap$2.06B
P/E—
PEG Ratio—
Div yield—
Beta2.57
CMPS Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)56.80%
Price vs S&P 500 (4W)27.82%
VGM Score80.72
CMPS Earnings Surprise History
Q2 25-0.41est. -0.37
Q3 25-0.38est. -0.41
Q4 25-0.61est. -0.39
Q1 26-0.30est. -0.32
Q2 26-0.36est. -0.34
CMPS Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.15
4.23
4.26
4.25
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CMPSCOMPASS Pathways Plc American Depository Shares | — | — | A | $14.88 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About COMPASS Pathways Plc American Depository Shares
Compass Pathways is a mental health company developing psilocybin-based therapies for treatment-resistant depression (TRD), a severe form of major depressive disorder with limited existing treatment options. The company's approach combines its proprietary high-purity psilocybin formulation (COMP360) with psychological support to create a comprehensive treatment model. By targeting an underserved patient population, Compass addresses a significant unmet medical need in mental health care.